Erik B.
- Country
- Belgium
- Department
- NA
Research Overview
- Evaluation of V540A Vaccine Efficacy in Preventing Human Papillomavirus Infection in Healthy Adults
- A Phase II Study of MK-1045 in Patients with Systemic Lupus Erythematosus or Rheumatoid Arthritis
- Effect of Muvalaplin on Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) and Atherosclerotic Cardiovascular Disease: A Phase 3 Randomized Trial
Data & Insights
Has run more than one trial at 338 of 1055 partner sites.
Specializations
Neurology & Sleep Disorders
The investigator specializes in treating narcolepsy conditions, with particular focus on both Type 1 (with cataplexy) and Type 2 variants. Their research encompasses the evaluation of novel therapeutic approaches for managing excessive daytime sleepiness.
- Narcolepsy Type 1 and Type 2 management
- Sleep disorder therapeutics
- Cataplexy treatment approaches
Mental Health & Neuropsychiatry
The investigator focuses on treating major depressive disorder and related conditions, including innovative approaches for managing treatment-resistant depression and anhedonia. They also investigate therapies for Alzheimer's-related psychosis and agitation.
- Depression treatment optimization
- Alzheimer's disease complications
- Psychosis management
Preventive Medicine & Immunology
The investigator conducts research in preventive medicine through vaccine development and evaluation, focusing on pneumococcal immunization, respiratory syncytial virus protection, and influenza prevention.
- Pneumococcal vaccine studies
- RSV immunization
- Influenza prevention
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.